相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
Interferon-alfa, interferon-lambda and hepatitis C
Thomas R. O'Brien
NATURE GENETICS (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rapid virologic response: A new milestone in the management of chronic hepatitis C
Fred Poordad et al.
CLINICAL INFECTIOUS DISEASES (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L. Shiffman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy
Rami Moucari et al.
JOURNAL OF HEPATOLOGY (2007)
Impact of reducing peginterferon alfa-2a and ribavirin dose during Retreatment in patients with chronic hepatitis C
Mitchell L. Shiffman et al.
GASTROENTEROLOGY (2007)
Interferon-induced depression in chronic hepatitis C
Y. Horsmans
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes
Sean E. Doyle et al.
HEPATOLOGY (2006)
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy
DM Jensen et al.
HEPATOLOGY (2006)
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
P Ferenci et al.
JOURNAL OF HEPATOLOGY (2005)
Treatment of hepatitis C
J Heathcote et al.
JOURNAL OF VIRAL HEPATITIS (2005)
The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain
RP Donnelly et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
分享论文
